| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |